The DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Helicobacter pylori: gastric cancer and beyond
Open accessAbstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 201–300 of 1,000
Global burden of five major types of gastrointestinal cancer
Singh, A. (2024) · Gastroenterology Review · doi:10.5114/pg.2024.141834 · Cited by 93
“Expanded access to HBV vaccination, cancer screening, early detection, and treat-ment services are needed to reduce GI cancer burden in Africa [19].”
Yang, T., Zeng, H., Chen, W., Zheng, R., Zhang, Y., Li, Z., Qi, J., Wang, M., Chen, T., Lou, J., et al. (2016) · Cancer Epidemiology · doi:10.1016/j.canep.2016.08.015 · Cited by 71
“The etiology of GC is caused by multiple genetic dysregulation in combination with various environmental factors and bacterial virulence factors [33–35].”
BackgroundThe Hippo pathway as a drug target in gastric cancer
Qiao, Y., Li, T., Zheng, S., & Wang, H. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.062 · Cited by 72
Diversity of macaque microbiota compared to the human counterparts
Chen, Z., Yeoh, Y. K., Hui, M., Wong, P. Y., Chan, M. C. W., Ip, M., Yu, J., Burk, R. D., Chan, F. K. L., & Chan, P. K. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-33950-6 · Cited by 75
Wu, Y., Song, Z., Deng, G., Jiang, K., Wang, H., Zhang, X., & Han, H. (2021) · Small · doi:10.1002/smll.202006877 · Cited by 70
Palbociclib-induced autophagy and senescence in gastric cancer cells
Valenzuela, C. A., Vargas, L., Martinez, V., Bravo, S., & Brown, N. E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.09.031 · Cited by 73
Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination
Maleki, H., Barzegari, A., Dehghani, J., Hanifian, S., Saeedi, N., Barar, J., & Omidi, Y. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0867-1 · Cited by 70
Im, B. N., Shin, H., Lim, B., Lee, J., Kim, K. S., Park, J. M., & Na, K. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120745 · Cited by 71
Helicobacter pylori Requires TlpD-Driven Chemotaxis To Proliferate in the Antrum
Rolig, A. S., Shanks, J. A., Carter, J. E., & Ottemann, K. M. (2012) · Infection and Immunity · doi:10.1128/iai.00407-12 · Cited by 83
“pylori triggers gastric inflammation, also known as gastritis, which can lead to a wide range of disease outcomes, such as mild gastritis, gastric and peptic ulcers, gastric adenocarcinoma, and mucosaassociated lymphoid tissue (MALT) lymphoma (38).”
BackgroundDuell, E. J., Sala, N., Travier, N., Muñoz, X., Boutron‐Ruault, M., Clavel‐Chapelon, F., Barricarte, A., Arriola, L., Navarro, C., Sánchez‐Cantalejo, E., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr285 · Cited by 72
Suárez, G., Romero–Gallo, J., Piazuelo, M. B., Sierra, J. C., Delgado, A. G., Washington, M. K., Shah, S. C., Wilson, K. T., & Peek, R. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2651 · Cited by 69
“However, only a percentage of colonized persons ever develop gastric neoplasia (3).”
BackgroundSelf-citationBasophils: Historical Reflections and Perspectives
Marone, G., Borriello, F., Varricchi, G., Genovese, A., & Granata, F. (2014) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000358734 · Cited by 68
Yang, T., Wang, R., Zhang, J., Bao, C., Zhang, J., Li, R., Chen, X., Wu, S., Wen, J., Wei, S., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117456 · Cited by 73
High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer
Liu, Y., Zhang, Y., Zhao, Y., Gao, D., Xing, J., & Liu, H. (2016) · Oncology Letters · doi:10.3892/ol.2016.5169 · Cited by 67
“H. pylori may induce apoptosis of gastric epithelial cells (45,46), and H. pylori infection is a risk factor associated with gastric cancer (47,48).”
Pan, M., Wan, C., Xie, Q., Huang, R., Tao, X., Shah, N. P., & Wei, H. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-10510 · Cited by 66
“Helicobacter pylori is a highly prevalent pathogen that colonizes approximately half of the world’s population (Polk and Peek, 2010; Wroblewski et al., 2010).”
BackgroundMiranti, E., Stolzenberg‐Solomon, R. Z., Weinstein, S. J., Selhub, J., Männistö, S., Taylor, P. R., Freedman, N. D., Albanes, D., Abnet, C. C., & Murphy, G. A. (2017) · International Journal of Cancer · doi:10.1002/ijc.30809 · Cited by 66
“C an ce r E pi de m io lo gy H. pylori infection is the strongest known initiator of the neoplastic sequence that leads to NCGA.37,38 H. pylori infection is also associated with food-bound vitamin B12 malabsorption39–41 likely due to induction of atrophic gastritis and accompanying achlorhydria (increase in gastric pH…”
BackgroundInfluentialDual character of Toll-like receptor signaling: Pro-tumorigenic effects and anti-tumor functions
Yu, L., Wang, L., & Chen, S. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.006 · Cited by 75
“Helicobacter pylori infection causes chronic gastritis and peptic ulceration and is the strongest known risk factor for the development of gastric cancer [8].”
A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?
Januszewicz, W., Turkot, M. H., Malfertheiner, P., & Reguła, J. (2023) · Cancers · doi:10.3390/cancers15030664 · Cited by 69
Molecular cross-talk between Helicobacter pylori and human gastric mucosa
Ricci, V., Romano, M., & Boquet, P. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i11.1383 · Cited by 76
Liu, J., He, L., Haesebrouck, F., Gong, Y., Flahou, B., Cao, Q., & Zhang, J. (2014) · Helicobacter · doi:10.1111/hel.12201 · Cited by 63
Mucin-Type O-Glycosylation in Gastric Carcinogenesis
Duarte, H. O., Freitas, D. P., Gomes, C., Gomes, J., Magalhães, A., & Reis, C. A. (2016) · Biomolecules · doi:10.3390/biom6030033 · Cited by 67
“pylori) bacterium, classified as a type I human carcinogen [2], and host genetic susceptibility [1,3].”
BackgroundRomán-Román, A., Martínez-Carrillo, D. N., Atrisco-Morales, J., Azúcar-Heziquio, J. C., Cuevas-Caballero, A. S., Castañón‐Sánchez, C. A., Reyes-Ríos, R., Betancourt-Linares, R., Reyes-Navarrete, S., Carmen, I. C.-D., et al. (2017) · Gut Pathogens · doi:10.1186/s13099-017-0167-z · Cited by 68
“This result is consistent with the activity of CagA to induce epithelial-mesenchymal transition and cell proliferation, inhibit apoptosis, promote the loss of tight junctions and carry out other functions related to tumor invasiveness and metastasis [53, 66].”
BackgroundResultKang, H., & Kim, H. (2017) · Journal of Cancer Prevention · doi:10.15430/jcp.2017.22.2.57 · Cited by 63
“imbalance of the apoptotic and proliferative process in the infected tissues.(3,4) Oxidative damage indices such as lipid”
BackgroundSougleri, I. S., Παπαδάκος, Κ. Σ., Zadik, M. P., Mavri‐Vavagianni, M., Mentis, A. F., & Sgouras, D. N. (2015) · FEBS Journal · doi:10.1111/febs.13592 · Cited by 62
Yum, H.-W., Na, H., & Surh, Y. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.004 · Cited by 64
Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer
Wang, J., Liu, Y., Sun, W., Zhang, Q., Gu, T., & Li, G. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170738 · Cited by 61
“Helicobacter pylori is a gram-negative bacterium that colony in human gastric epithelium, and is associated with the pathogenesis of gastric disorders, such as atrophic gastritis, peptic ulcers, and gastric cancer [63– 65].”
Endoplasmic reticulum proteostasis control and gastric cancer
Wang, Y., Wang, K., Jin, Y., & Sheng, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.034 · Cited by 62
Financial Inhibition, Financial Activation, and Saving for Retirement
Neukam, K. A., & Hershey, D. A. (2003) · Financial Services Review · doi:10.61190/fsr.v12i1.4752 · Cited by 60
DNA transfer in the gastric pathogen Helicobacter pylori
Fernández-González, E., & Backert, S. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-014-0938-y · Cited by 65
“pylori is commonly transmitted in early childhood and can persist throughout the entire lifetime of the host due to its ability to adapt to changes in its environmental niche [1, 2].”
BackgroundLoh, J. T., Friedman, D. B., Piazuelo, M. B., Bravo, L. E., Wilson, K. T., Peek, R. M., Correa, P., & Cover, T. L. (2012) · Infection and Immunity · doi:10.1128/iai.00232-12 · Cited by 59
“pylori infection is determined by a combination of bacterial, host, and environmental factors (1, 2, 9, 31, 35).”
BackgroundSelf-citationZhu, H., Wang, Q., Yao, Y., Fang, J., Sun, F., Ni, Y., Shen, Y., Wang, H., & Shao, S. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0159-0 · Cited by 59
“The clinical outcome, ranging from chronic gastritis to peptic ulcers, even to cancer or mucosaassociated lymphoid tissue (MALT) lymphoma, is caused by multiple interior genetic dysregulation in combination with various environmental factors and bacterial virulence factors [2, 3].”
BackgroundShi, Y., Yang, Z., Zhang, T., Shen, L., Li, Y., & Ding, S. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1859-8 · Cited by 59
Su, Y.-L., Huang, H.-L., Huang, B., Chen, P.-C., Chen, C., Wang, H.-L., Lin, P.-H., Chieh, M.-S., Wu, J.-J., Yang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep36442 · Cited by 58
The Pivotal Role of DNA Repair in Infection Mediated-Inflammation and Cancer
Sahan, A. Z., Hazra, T. K., & Das, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00663 · Cited by 59
The Gum–Gut Axis: Periodontitis and the Risk of Gastrointestinal Cancers
Baima, G., Ribaldone, D. G., Romano, F., Aimetti, M., & Romandini, M. (2023) · Cancers · doi:10.3390/cancers15184594 · Cited by 60
“Prolonged infection with this pathogen has been identified as the leading risk factor for the main type of gastric cancer, adenocarcinoma (GACC) [90].”
BackgroundGastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma
Chen, Z., Saad, R., Jia, P., Peng, D., Zhu, S., Washington, M. K., Zhao, Z., Xu, Z., & El-Rifai, W. M. (2013) · Cancer · doi:10.1002/cncr.28002 · Cited by 57
Pro-inflammatory properties and neutrophil activation by Helicobacter pylori urease
Uberti, A. F., Olivera‐Severo, D., Wassermann, G. E., Guerra, A. S., Moraes, J. A., Barcellos‐de‐Souza, P., Barja‐Fidalgo, C., & Carlini, C. R. (2013) · Toxicon · doi:10.1016/j.toxicon.2013.02.009 · Cited by 57
Inflammasome Activation by Helicobacter pylori and Its Implications for Persistence and Immunity
Pachathundikandi, S. K., Mueller, A., & Backert, S. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_6 · Cited by 62
Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets
Szebeni, G. J., Vízler, C., Nagy, L. I., Kitajka, K., & Puskás, L. G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111958 · Cited by 61
“On the other hand, inflammation predisposing for cancer can be driven extrinsically by infections (Helicobacter pylori, hepatitis) [7,8], autoimmune diseases (Crohn’s disease, ulcerative colitis) [9], chronic exposure to irritants (asbestos) [10,11] or by multiplex factors like in the case of prostatitis influenced by…”
BackgroundZhang, X. Y., Soutto, M., Chen, Z., Bhat, N. S., Zhu, S., Eissmann, M. F., Ernst, M., Lu, H., Peng, D., Xu, Z., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.05.016 · Cited by 57
Jiang, S., Ma, W., Ma, C., Zhang, Z., Zhang, W., & Zhang, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341717 · Cited by 57
“57 Gastric cancer risk was considerably decreased following the elimination of H. pylori .”
BackgroundPan, K., Formichella, L., Zhang, L., Zhang, Y., Ma, J., Li, Z., Liu, C., Wang, Y., Göttner, G., Ulm, K., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28560 · Cited by 56
“Recently, additional H. pylori virulence factors were identified as new risk markers for GC, such as chaperonin GroEL and Helicobacter cysteine-rich protein C (HcpC).13,14 An epidemiologic study analyzing antibody responses toward 15 individual H. pylori proteins revealed that seropositivities of CagA and GroEL were i…”
BackgroundInfluentialKrakowiak, M. S., Noto, J. M., Piazuelo, M. B., Hardbower, D. M., Romero–Gallo, J., Delgado, A., Chaturvedi, R., Corréa, P., Wilson, K. T., & Peek, R. M. (2014) · Oncogene · doi:10.1038/onc.2014.135 · Cited by 56
Self-citationMultiple Infections and Cancer: Implications in Epidemiology
Vedham, V., Divi, R. L., Starks, V. L., & Verma, M. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500366 · Cited by 60
Helicobacter pylori actively suppresses innate immune nucleic acid receptors
Dooyema, S. D. R., Noto, J. M., Wroblewski, L. E., Piazuelo, M. B., Krishna, U. S., Suárez, G., Romero–Gallo, J., Delgado, A. G., & Peek, R. M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2105102 · Cited by 61
Self-citationCosta, Â. M., Ferreira, R. M., Pinto-Ribeiro, I., Sougleri, I. S., Oliveira, M. J., Carreto, L. C., Santos, M. A. S., Sgouras, D. N., Carneiro, F., Leite, M., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw031 · Cited by 55
“remains for the lifetime of the host [1].”
BackgroundKim, J. M., Kim, J. S., Yoo, D. Y., Ko, S. H., Kim, N., Kim, H. C., & Kim, Y.-J. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04447.x · Cited by 57
Loh, J. T., Shaffer, C. L., Piazuelo, M. B., Bravo, L. E., McClain, M. S., Correa, P., & Cover, T. L. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0548 · Cited by 54
“Global diagnoses were assigned on an ordinal scale from (1) to (6), as follows: (1) mild to moderate nonatrophic gastritis; (2) severe nonatrophic gastritis; (3) multifocal atrophic gastritis without intestinal metaplasia; (4) intestinal metaplasia (IM); (5) dysplasia; and (6) adenocarcinoma.”
MethodLin, F., Liu, Y.-P., Lai, C.-H., Shan, Y.-S., Cheng, H., Hsu, P.-I., Lee, C.-H., Lee, Y.-C., Wang, H.-Y., Wang, C., et al. (2012) · Oncogene · doi:10.1038/onc.2011.596 · Cited by 62
Helicobacter pylori point-of-care diagnosis: Nano-scale biosensors and microfluidic systems
Nosrati, R., Golichenari, B., Nezami, A., Taghdisi, S. M., Karimi, B., Ramezani, M., Abnous, K., & Shaegh, S. A. M. (2017) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2017.10.013 · Cited by 57
Nanoparticle binding attenuates the pathobiology of gastric cancer-associated Helicobacter pylori
Westmeier, D., Posselt, G., Hahlbrock, A., Bartfeld, S., Vallet, C., Abfalter, C. M., Docter, D., Knauer, S. K., Weßler, S., & Stauber, R. H. (2017) · Nanoscale · doi:10.1039/c7nr06573f · Cited by 54
S100A12 in Digestive Diseases and Health: A Scoping Review
Carvalho, A., Lu, J., Francis, J. D., Moore, R. E., Haley, K. P., Doster, R. S., Townsend, S. D., Johnson, J. G., Damo, S. M., & Gaddy, J. A. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/2868373 · Cited by 54
“pylori infection is the single biggest risk factor associated with gastric cancer, and gastritis is a critical process in the precancerous signaling cascade [53, 54].”
BackgroundXiao, F., Chen, S., Li, L., Xu, X., Wang, H., Ke, H., He, C., Xie, C., Wu, X., Liu, J., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-024-02017-7 · Cited by 53
“The pathogenic virulence factors cytotoxin-associated gene (CagA) and vacuolating toxin A (VacA) have been recognized to play an important role in the development of H. pylori -related gastric disorders [7].”
Trefoil factors: Gastrointestinal-specific proteins associated with gastric cancer
Xiao, P., Ling, H. Y., Lan, G., Liu, J., Hu, H., & Yang, R. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.08.004 · Cited by 53
Noto, J. M., Khizanishvili, T., Chaturvedi, R., Piazuelo, M. B., Romero–Gallo, J., Delgado, A. G., Khurana, S. S., Sierra, J. C., Krishna, U. S., Suárez, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054344 · Cited by 53
“flammatory and mitogenic responses [2].”
BackgroundSelf-citationZambelli, B., Berardi, A., Martin‐Diaconescu, V., Mazzei, L., Musiani, F., Maroney, M. J., & Ciurli, S. (2013) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-013-1068-3 · Cited by 53
Prognostic role of ARID1A negative expression in gastric cancer
Ashizawa, M., Saito, M., Min, A. K. T., Ujiie, D., Saito, K., Sato, T., Kikuchi, T., Okayama, H., Fujita, S., Endo, H., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43293-5 · Cited by 56
Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
Che, B., Zhang, W., Xu, S., Yin, J., He, J., Huang, T., Li, W., Yu, Y., & Tang, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.805459 · Cited by 58
“The increased risk of cancer caused by changes in microbiota has been confirmed in other tumors (8).”
BackgroundDuell, E. J., Lujan-Barroso, L., Llivina, C., Muñoz, X., Jenab, M., Boutron-Ruault, M.-C., Clavel-Chapelon, F., Racine, A., Boeing, H., Buijsse, B., et al. (2013) · Genes & Nutrition · doi:10.1007/s12263-013-0346-6 · Cited by 52
Gastric microbiota in gastric cancer: Different roles of Helicobacter pylori and other microbes
Guo, Y., Cao, X., Zhou, M., & Yu, B. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1105811 · Cited by 52
From Germ Theory to Germ Therapy: Skin Microbiota, Chronic Wounds, and Probiotics
Wong, V., Martindale, R. G., Longaker, M. T., & Gurtner, G. C. (2013) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3182a3c11e · Cited by 57
Ferreira, R. M., Pinto-Ribeiro, I., Wen, X., Marcos‐Pinto, R., Dinis-Ribeiro, M. J., Carneiro, F., & Figueiredo, C. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv467 · Cited by 52
“world’s population and is the major risk factor for gastric carcinoma [1].”
BackgroundMouse models for gastric cancer: Matching models to biological questions
Poh, A. R., O’Donoghue, R. J. J., Ernst, M., & Putoczki, T. L. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13297 · Cited by 60
Bacteriophages of Helicobacter pylori
Muñoz, A. B., Stepanian, J., Trespalacios, A. A., & Vale, F. F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.549084 · Cited by 52
“In the early 1990s, a lysogenic strain of H. pylori that produced phage particles spontaneously was described (Schmid et al., 1990).”
BackgroundPachathundikandi, S. K., Blaser, N., Bruns, H., & Backert, S. (2020) · Cancers · doi:10.3390/cancers12040803 · Cited by 58
“pylori is a bacterial carcinogen recognized by the World Health Organization (WHO) due to the association with gastric cancer and MALT lymphoma [5].”
BackgroundNLRP3 inflammasome-induced pyroptosis in digestive system tumors
Wen, J., Xuan, B., Liu, Y., Wang, L., He, L., Meng, X., Zhou, T., & Wang, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1074606 · Cited by 53
Gong, H., Wang, X., Hu, X., Liao, M., Yuan, C., Lu, J. R., Gao, L., & Yan, X. (2024) · Biomacromolecules · doi:10.1021/acs.biomac.3c01141 · Cited by 51
Yeh, C., Chang, L.-Y., Lin, S., Chou, J., Hsieh, H., Zeng, L.-H., Chuang, S.-Y., Wang, H.-W., Dittner, C., Lin, C.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep31690 · Cited by 51
Probiotics as an adjuvant treatment in Helicobacter pylori eradication therapy
Zhu, X. Y., & Liu, F. (2017) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12466 · Cited by 54
Lu, S., Wang, C., Ma, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1456030 · Cited by 56
“Initially, commensal microbiota was considered pathogens and implicated in certain cancers, like Helicobacter pylori in gastric cancer (261, 262).”
BackgroundDe-coding the complex role of microbial metabolites in cancer
Escriva, P. P., Bernardino, C. C. T., & Letellier, E. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115358 · Cited by 54
Khan, A. A., Khan, Z., & Warnakulasuriya, S. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw053 · Cited by 53
Siemer, S., Hahlbrock, A., Vallet, C., McClements, D. J., Balszuweit, J., Voskuhl, J., Docter, D., Weßler, S., Knauer, S. K., Westmeier, D., et al. (2018) · npj Science of Food · doi:10.1038/s41538-018-0030-8 · Cited by 52
Chen, Z., Li, Z., Soutto, M., Wang, W., Piazuelo, M. B., Zhu, S., Guo, Y. P., Maturana, M. J., Corvalán, A. H., Chen, X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.052 · Cited by 52
Flint, A., Stintzi, A., & Saraiva, L. M. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuw025 · Cited by 54
“…the vacuolating cytotoxin (vacA), and cytotoxin-associated gene A and L (cagA and cagL), have been proposed to have an augmented risk for malignancy including gastric cancer (Polk and Peek 2010; Yamaoka 2010; Salama, Hartung and Muller 2013; Hardbower, Peek and Wilson 2014; Kaakoush et al. 2015).”
BackgroundInterplay between viruses and bacterial microbiota in cancer development
Vyshenska, D., Lam, K. C., Shulzhenko, N., & Morgun, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.05.003 · Cited by 52
“For example, Helicobacter pylori causes gastric adenocarcinoma and is a classic case of oncogenic bacteria [15].”
BackgroundEom, J. W., Lim, J. W., & Kim, H. (2023) · Molecules · doi:10.3390/molecules28031178 · Cited by 51
“pylori infection is considered the most important cause of gastric cancer [3].”
BackgroundHelicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE
Liu, S., Zhang, N., Ji, X., Yang, S., Zhao, Z., & Li, P. (2025) · Cell Death and Disease · doi:10.1038/s41419-024-07318-w · Cited by 49
“CagA, a signi fi cant virulence factor of H. pylori , plays a crucial role in the initiation and progression of gastric cancer [28].”
He, C., Yang, Z., & Lü, N. (2016) · Helicobacter · doi:10.1111/hel.12297 · Cited by 54
p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?
Li, N., Xie, C., & Lü, N. (2016) · Oncotarget · doi:10.18632/oncotarget.11414 · Cited by 51
“pylori, which is primarily acquired during childhood [1-3].”
BackgroundWei, S., Lu, J., Lou, J., Shi, C., Mo, S., Shao, Y., Ni, J., Zhang, W., & Cheng, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00663 · Cited by 61
Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review)
Wang, D., Sang, Y., Sun, T., Kong, P., Zhang, L., Dai, Y., Cao, Y., Tao, Z., & Liu, W. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5200 · Cited by 49
“Helicobacter pylori infection acts as a trigger in the carcinogenesis of gastric cancer (71), and increasing studies (53,72) suggest that H.”
BackgroundBacteria-based immune therapies for cancer treatment
Howell, L. M., & Forbes, N. S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.09.006 · Cited by 48
Gastric Organoids: Progress and Remaining Challenges
Pang, M.-J., Burclaff, J., Jin, R. U., Adkins-Threats, M., Osaki, L. H., Han, Y., Mills, J. C., Miao, Z., & Wang, Z.-N. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.09.005 · Cited by 50
Libânio, D., Dinis-Ribeiro, M. J., & Pimentel‐Nunes, P. (2015) · World Journal of Clinical Oncology · doi:10.5306/wjco.v6.i5.111 · Cited by 49
Bacterial-binding chitosan microspheres for gastric infection treatment and prevention
Gonçalves, I. C., Magalhães, A., Fernandes, M., Rodrigues, I. V., Reis, C. A., & Martins, M. C. L. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.034 · Cited by 48
“pylori has been associated with an increased risk of development of gastritis, peptic ulcer and gastric cancer [3,4].”
BackgroundTegtmeyer, N., & Backert, S. (2011) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.11.006 · Cited by 48
Immunotherapy for Gastroesophageal Cancer
Goode, E., & Smyth, E. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5100084 · Cited by 48
“pylori) is believed to cause up to fifty percent of gastric cancers and accounts much geographical variation in incidence [5,52].”
BackgroundTIP60 represses activation of endogenous retroviral elements
Rajagopalan, D., Tirado-Magallanes, R., Bhatia, S. S., Teo, W. S., Sian, S., Hora, S., Lee, K. K., Zhang, Y., Jadhav, S. P., Wu, Y., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky659 · Cited by 51
“Bacterial or viral infection-mediated inflammatory processes can potentially accelerate tumorigenesis, as suggested by the strong association between Crohn’s disease or chronic ulcerative colitis and colorectal cancer (43); Helicobacter pylori infection and gastric cancer (59); human papillomavirus infection and cervi…”
BackgroundGastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
Buckley, K. H., Niccum, B. A., Maxwell, K. N., & Katona, B. W. (2022) · Cancers · doi:10.3390/cancers14235953 · Cited by 47
“pylori is a well-established pathogen that can promote progression through this pathway via promotion of chronic gastritis [54].”
BackgroundKang, D. W., Hwang, W. C., Park, M. H., Ko, G. H., Ha, W.-S., Kim, K.-S., Lee, Y.-C., Choi, K.-Y., & Min, D. S. (2012) · Oncogene · doi:10.1038/onc.2012.358 · Cited by 49
Shimizu, T., Choi, E.-Y. K., Petersen, C. P., Noto, J. M., Romero–Gallo, J., Piazuelo, M. B., Washington, M. K., Peek, R. M., & Goldenring, J. R. (2016) · The Journal of Pathology · doi:10.1002/path.4735 · Cited by 47
“pylori-infected gastric mucosa with chronic gastritis, atrophy, and metaplastic changes [4].”
Self-citationOsakunor, D. N. M., Sengeh, D. M., & Mutapi, F. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006711 · Cited by 47
“Information adapted from Crosbie, Einstein, and colleagues, 2013 [16]; Ahmadi Ghezeldasht, Shirdel, and colleagues, 2013 [55]; Marra, Sordelli, and colleagues, 2011 [56]; Mostafa, Sheweita, and colleagues, 1999 [57]; Dittmer and Damania, 2016 [58]; Polk and Peek, 2010 [59]; and Bower, Nelson, and colleagues, 2005 [17].”
Implications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 47
Helicobacter pyloriin First Nations and Recent Immigrant Populations in Canada
Jones, N. L., Chiba, N., Fallone, C. A., Thomson, A. B. R., Hunt, R. H., Jacobson, K., & Goodman, K. J. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/174529 · Cited by 46
“Specific histological or clinical characteristics associated with increased gastric cancer risk, such as atrophy, intestinal metaplasia and achlorhydria, may also be linked to these or other virulence factors (34).”
BackgroundDownregulation of tumor suppressor MBP-1 by microRNA-363 in gastric carcinogenesis.
Hsu, K.-W., Wang, A.-M., Ping, Y.-H., Huang, K.-H., Huang, T.-T., Lee, H.-C., Lo, S., Chi, C., & Yeh, T.-S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt285 · Cited by 48
“The risk factors of gastric cancer include diet, Helicobacter pylori infection and specific genetic alterations (3,4).”
BackgroundAutoimmunity as a Double Agent in Tumor Killing and Cancer Promotion
Toomer, K. H., & Chen, Z. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00116 · Cited by 47
The gastrointestinal microbiota and its role in oncogenesis
Lam, S. Y., Yu, J. Q., Wong, S. H., Peppelenbosch, M. P., & Fuhler, G. M. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.010 · Cited by 50
Guo, Y., Cao, X., Guo, G.-Y., Zhou, M., & Yu, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.899248 · Cited by 46
“…major characteristics of H. pylori infection-induced gastric microbiota dysbiosis include reduced microbial diversity, altered microbial community structure, composition, bacterial interactions, etc. (MaldonadoContreras et al., 2011; Coker et al., 2017; Parsons et al., 2017; Schulz et al., 2018).”
BackgroundRolig, A. S., Carter, J. E., & Ottemann, K. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104598108 · Cited by 52
“Inflammation is promoted by both host factors (2) andH.”
Background
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.